About Us
ABOUT US
Delivering Hope Through Safe, Legal & Authentic Medicine Access.
S S Health Connect is a global pharmaceutical access organization committed to making life-saving and rare disease medicines reachable for patients around the world. Our purpose is to bridge the treatment gap for medicines that are not yet available, registered or commercially marketed in many countries. With more than 20 years of industry knowledge in specialty drug sourcing and international pharma coordination, we support patients, families, doctors, hospitals and healthcare providers by enabling safe, compliant and ethical access to critical therapies.
We work closely with authorized manufacturers, licensed distributors and regulatory pathways to ensure that every medicine we supply is genuine, original and processed under proper documentation. Our focus spans multiple therapeutic categories including Oncology, Breast Cancer, Immunology, Nephrology, Hepatitis, Cardiology and other Rare Disease segments. We take responsibility not only in finding the medicine — but also in guiding patients through every step until safe delivery.
At S S Health Connect, we believe that the right medicine should never be limited by borders. Our goal is to empower access, reduce waiting time, eliminate uncertainty and make global medicines reachable to the people who need them most
20+
Years of Pharma Access Expertise
100%
Authorized Genuine Medicines Only
30+
Global Supply Countries Supported
Connecting Patients to World-Class Medicines
Providing Legal, Safe & Early Access to Essential Medicines
S S Health Connect offers regulated access pathways that enable patients to receive innovative and life-saving medicines that are not yet commercially approved or available in their country.
Named Patient Program (NPP)
Allows individual patients access to non-approved or unavailable medicines based on a doctor’s prescription, especially in cases with limited or no existing treatment options.
Managed Access Program (MAP)
Supports controlled access to new and innovative medicines while they await commercial launch or market approvals, ensuring eligible patients receive treatment at the right time.
Early Access Program (EAP)
Provides access to promising investigational therapies before full regulatory approval, helping patients benefit from advanced treatment earlier while formal approvals are still in process
Benefit
Making Global Medical Innovation Reach Every Patient Who Needs It.
Access Beyond Local Market Limitations
Patients receive medicines even if their country has not approved, listed, or commercially launched the required treatment.
Global Innovation Without Borders
This model empowers patients to access the latest global medical advancements, clinical innovation and breakthrough therapies early.
Eliminates the Risk of Fake & Unverified Sources
Instead of patients struggling themselves or ending up buying from unsafe or unknown sources — access programs ensure authenticated, original products only.
Doctor Supported & Evidence Based Selection
Medicines provided through access programs are chosen based on physician requirement, medical need and verified therapeutic justification — not random self-medication.
Our Commitment
Our Promise to Patients and Healthcare Providers
S S Health Connect operates on ethics, transparency and global compliance. Every medicine we supply is processed only against a valid prescription from a registered medical practitioner, and we do not deal in narcotics, sedatives or controlled substance misuse. Our responsibility is to ensure that patients receive genuine, original and safe treatments — sourced legally and delivered with verified documentation.
We are committed to supporting patients and doctors with honest communication, trusted sourcing, and reliable access — so no one is denied a life-saving therapy due to geographical or regulatory limitations.
